top of page
  • Henry Seaton

DOT adds four opioids to drug testing rule

The U.S. Department of Transportation (DOT) on November 13 issued a final rule that expands the department’s current drug testing panel for regulated industries, including safety-sensitive positions at motor carriers, to include four semi-synthetic opioids: Hydrocodone, hydromorphone, oxymorphone, and oxycodone. The rule takes effect January 1, 2018.

Other changes in the rule include adding methylenedioxyamphetamine as an initial test analyte and removing it as a confirmatory test analyte. The revision of the drug-testing panel harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U.S. Department of Health and Human Services for federal drug-testing programs for urine testing. The final rule also clarifies certain existing drug-testing program provisions and definitions, makes technical amendments, and removes the requirement for employers and consortium/third party administrators to submit blind specimens.

Avoid legal pitfalls

Rules of the Road offers practical help on avoiding legal pitfalls in working with customers, independent contractors, insurers, factoring companies, etc.

Many serious legal risks will go unnoticed unless you are watching for them. Don't take chances.

 Although successful food haulers already employ the common sense steps required in FDA's new transportation rule, declaring your compliance can help you stay competitive for spot-market freight. 

bottom of page